COVID A

UTHORS

Online profiles of coronavirus experts

COVID-19 therapeutic options for patients with kidney disease.

COVID-19 therapeutic options for patients with kidney disease. Kidney Int. 2020 06; 97(6):1297-1298.

View in: PubMed

subject areas
  • Antiviral Agents
  • Betacoronavirus
  • Coronavirus Infections
  • Dose-Response Relationship, Drug
  • Drug Dosage Calculations
  • Glomerular Filtration Rate
  • Humans
  • Kidney
  • Off-Label Use
  • Pandemics
  • Pneumonia, Viral
  • Renal Elimination
  • Renal Insufficiency, Chronic

authors with profiles
  • Kenar D Jhaveri
  • Mark A Perazella
  • Hassan Izzedine


COVID Authors was created by the Weber Lab at Harvard Medical School and powered by Profiles Research Networking Software. Data for this website came from LitCovid [Chen Q, Allot A, Lu Z. Keep up with the latest coronavirus research. Nature. 2020;579(7798):193] and the PubMed Knowledge Graph [Xu J, Kim S, Song M, et al. Building a PubMed knowledge graph. Sci Data. 2020 Jun 26;7(1):205]. Additional data mappings generated for this website are available here. This website is not intended to be used to make medical decisions. Author profiles are generated by an automated algorithm. The accuracy of the information on those profiles is not guaranteed to be accurate. For more information about this website contact Griffin M Weber, MD, PhD, at weber@hms.harvard.edu.